Condition
Locally Advanced Bladder Urothelial Carcinoma clinical trials and research
Research outlook What's coming for Bladder cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Locally Advanced Bladder Urothelial Carcinoma clinical trials that are recruiting, in United States. By phase: Phase 1/2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Enfortumab Vedotin, Pembrolizumab, and Quemliclustat for unresectable or metastatic urothelial cancer
This trial tests a three-drug combination to see if it can safely treat unresectable or metastatic urothelial cancer in adults.
-
Combination of Enfortumab Vedotin and Pembrolizumab with Surgery for Advanced Bladder Cancer
This study is testing if a combination of two medications, enfortumab vedotin and pembrolizumab, can help people with advanced bladder cancer before they have surgery.
Related topics
Quick answers
How many Locally Advanced Bladder Urothelial Carcinoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.